Carpal Tunnel Syndrome and Amyloid Cardiomyopathy
1 other identifier
observational
96
1 country
1
Brief Summary
The investigators will prospectively evaluate tissue samples obtained from patients undergoing carpal tunnel release surgery for amyloid in the soft tissue that is removed. Patients who have tissue that stains positive for amyloid will undergo cardiac testing to look for evidence of cardiac involvement.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2016
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2016
CompletedFirst Submitted
Initial submission to the registry
April 20, 2016
CompletedFirst Posted
Study publicly available on registry
June 8, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 21, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 2, 2021
CompletedDecember 22, 2021
December 1, 2021
5.4 years
April 20, 2016
December 21, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Incidence of transthyretin (TTR) amyloidosis in patients undergoing carpal tunnel release surgery
Identify the incidence of TTR amyloid deposits in the soft tissue of patients undergoing carpal tunnel surgery for idiopathic carpal tunnel syndrome
Biopsy completed on day of surgery
Cardiac progression of transthyretin (TTR) amyloidosis in carpal tunnel biopsy-positive patients
Assess the progression of cardiac disease in patients with TTR deposits found in soft tissue removed at the time of carpal tunnel surgery
4 years from baseline cardiac assessment.
Secondary Outcomes (2)
Prevalence of abnormal transthyretin (TTR) kinetics in patients undergoing carpal tunnel surgery
One-time kinetics test for biopsy-negative patients; baseline kinetics and annually for 4 years in biopsy-positive patients
Early transthyretin (TTR) amyloid cardiomyopathy identification in carpal tunnel biopsy-positive patients
Baseline and annual testing for 4 years in biopsy-positive patients
Study Arms (1)
Patients with carpal tunnel syndrome.
Patients undergoing carpal tunnel release surgery.
Eligibility Criteria
Adult patients undergoing carpal tunnel release surgery for idiopathic carpal tunnel syndrome not responding conservative and medical management.
You may qualify if:
- Males ≥ 50 years of age
- Females ≥ 60 years of age
- Undergoing carpal tunnel release surgery (adequate symptoms are not responding to conservative management requiring surgery)
- Able to consent
- Underwent carpal tunnel surgery and biopsy within last 30 days, if the study was discussed prior to surgery by one of the study physicians.
You may not qualify if:
- Secondary CTS (Hemodialysis, rheumatoid arthritis, trauma)
- Known diagnosis of amyloidosis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Lutheran Hospital
Cleveland, Ohio, 44113, United States
Related Publications (1)
Sperry BW, Reyes BA, Ikram A, Donnelly JP, Phelan D, Jaber WA, Shapiro D, Evans PJ, Maschke S, Kilpatrick SE, Tan CD, Rodriguez ER, Monteiro C, Tang WHW, Kelly JW, Seitz WH Jr, Hanna M. Tenosynovial and Cardiac Amyloidosis in Patients Undergoing Carpal Tunnel Release. J Am Coll Cardiol. 2018 Oct 23;72(17):2040-2050. doi: 10.1016/j.jacc.2018.07.092.
PMID: 30336828DERIVED
Biospecimen
Blood will be stored in Cleveland Clinic to be used for the future studies.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mazen Hanna, MD
The Cleveland Clinic
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prinicipal Investigator
Study Record Dates
First Submitted
April 20, 2016
First Posted
June 8, 2016
Study Start
March 1, 2016
Primary Completion
July 21, 2021
Study Completion
December 2, 2021
Last Updated
December 22, 2021
Record last verified: 2021-12
Data Sharing
- IPD Sharing
- Will not share